GGrantIndex
Sort

46,585 grants matching heart failure

Device for Measuring Capillary Blood Flow and the Onset of Shock

$509,424
James F Christian · Radiation Monitoring Devices, Inc. · R44 · FY2015 · HL

Photochemical regulation of calcium in cell physiology

$509,346
Graham Ellis-Davies · Icahn School Of Medicine At Mount Sinai · R01 · FY2019 · GM

Photochemical regulation of calcium in cell physiology

$509,346
Graham Ellis-Davies · Icahn School Of Medicine At Mount Sinai · R01 · FY2020 · GM

Modified Late Infarct Reperfusion to Prevent Post MI CHF

$509,310
University Of Pennsylvania · R01 · FY2005 · HL

Defining the role of mitochondrial injury in MEK inhibitor cardiotoxicity

$509,288
Brian C Jensen · Univ Of North Carolina Chapel Hill · R01 · FY2024 · HL

Defibrillation Mechanisms in Infarcted Hearts

$509,269
Natalia A. Trayanova · Johns Hopkins University · R01 · FY2010 · HL

The role of REDD1 in insulin-mediated transcription

$509,241
Jessica Pfleger Karch · Virginia Polytechnic Inst And St Univ · R01 · FY2025 · HL

Molecular Genetics of Carney Complex

$509,200
Cathy J Hatcher · Weill Medical Coll Of Cornell Univ · R01 · FY2010 · HL

Mitochondrial Dysfunction and Susceptibility to Atrial Fibrillation in the Elderl

$509,165
Arshad Jahangir · Aurora Health Care, Inc. · R01 · FY2012 · HL

Cardiac Macrophages as Disease Drivers in Chronic Ischemic Heart Failure

$509,111
Sumanth D Prabhu · Washington University · R01 · FY2024 · HL

Genes That Regulate Target Organ Damage in Hypertension

$509,065
Duke University · R01 · FY2002 · HL

Project 3: Control of cardiac transcription by MEF2 and myocardin

$509,060
Brian L Black · J. David Gladstone Institutes · P01 · FY2023 · HL

Project 3: Control of cardiac transcription by MEF2 and myocardin

$509,060
Brian L Black · J. David Gladstone Institutes · P01 · FY2022 · HL

QT prolonging medications and sudden cardiac death among individuals on hemodialysis

$509,050
Jennifer E Flythe · Univ Of North Carolina Chapel Hill · R01 · FY2021 · HL

Neuropilin-2 in Alloimmunity

$509,048
David Michael Briscoe · Boston Children'S Hospital · R01 · FY2022 · AI

Neuropilin-2 in Alloimmunity

$509,048
David Michael Briscoe · Boston Children'S Hospital · R01 · FY2024 · AI

Neuropilin-2 in Alloimmunity

$509,048
David Michael Briscoe · Boston Children'S Hospital · R01 · FY2020 · AI

Neuropilin-2 in Alloimmunity

$509,048
David Michael Briscoe · Boston Children'S Hospital · R01 · FY2023 · AI

Neuropilin-2 in Alloimmunity

$509,048
David Michael Briscoe · Boston Children'S Hospital · R01 · FY2021 · AI

Epigenetic reprogramming of cardiac myofibroblasts for cardiac repair

$509,007
Yao Liang Tang · Augusta University · R01 · FY2025 · HL

Epigenetic reprogramming of cardiac myofibroblasts for cardiac repair

$509,007
Yao Liang Tang · Augusta University · R01 · FY2023 · HL

Determining the Role of the Potassium Channel, KCNN3, in Atrial Fibrillation

$509,003
Patrick Thomas Ellinor · Massachusetts General Hospital · R01 · FY2010 · HL

JACKSON HEART STUDY--EXAM CENTER

$509,000
University Of Mississippi Medical Center · N01 · FY2000 · HC

Genetics of lipoprotein metabolism and CVD in CKD

$508,989
Daniel James Rader · University Of Pennsylvania · R01 · FY2010 · HL

Ac-SDKP in the Treatment of Cardiac Dysfunction in Hypertension or Ischemic Heart

$508,983
Nour-Eddine Rhaleb · Henry Ford Health System · R01 · FY2018 · HL